ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
csrwin
|
451 |
133K |
1 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
451
|
133K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Valuation
|
|
csrwin
|
89 |
43K |
4 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
89
|
43K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
csrwin
|
451 |
133K |
2 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
451
|
133K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
csrwin
|
451 |
133K |
4 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
451
|
133K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
csrwin
|
451 |
133K |
12 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
451
|
133K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
csrwin
|
451 |
133K |
3 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
451
|
133K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
ASX Hot too!
|
|
csrwin
|
451 |
133K |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
451
|
133K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Chair Transition
|
|
csrwin
|
18 |
6.8K |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
18
|
6.8K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
csrwin
|
554 |
223K |
2 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
554
|
223K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Valuation
|
|
csrwin
|
89 |
43K |
27 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
89
|
43K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
csrwin
|
17K |
6.6M |
3 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
17K
|
6.6M
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
csrwin
|
92 |
20K |
1 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
92
|
20K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
csrwin
|
554 |
223K |
6 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
554
|
223K
|
6
|
|
Charts
|
MSB |
Re:
chart
|
|
csrwin
|
32 |
13K |
1 |
23/04/24 |
23/04/24 |
Charts
|
32
|
13K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
CLBP Trial 2024
|
|
csrwin
|
6 |
2.4K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
6
|
2.4K
|
2
|
|
ASX - By Stock
|
MSB |
CLBP Trial 2024
|
|
csrwin
|
6 |
2.4K |
16 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
6
|
2.4K
|
16
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
csrwin
|
92 |
20K |
0 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
92
|
20K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
csrwin
|
92 |
20K |
0 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
92
|
20K
|
0
|
|
Charts
|
MSB |
Re:
chart
|
|
csrwin
|
32 |
13K |
1 |
19/04/24 |
19/04/24 |
Charts
|
32
|
13K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
csrwin
|
92 |
20K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
92
|
20K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
csrwin
|
92 |
20K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
92
|
20K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
csrwin
|
273 |
115K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
273
|
115K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
csrwin
|
92 |
20K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
92
|
20K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
csrwin
|
273 |
115K |
5 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
273
|
115K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Jane Bell
|
|
csrwin
|
38 |
18K |
19 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
38
|
18K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Jane Bell
|
|
csrwin
|
38 |
18K |
13 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
38
|
18K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Jane Bell
|
|
csrwin
|
38 |
18K |
0 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
38
|
18K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
9.5K |
2.8M |
1 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
1
|
|
Charts
|
ACW |
Re:
ACW Chart Thread
|
|
csrwin
|
24 |
8.5K |
0 |
04/04/24 |
04/04/24 |
Charts
|
24
|
8.5K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
9.5K |
2.8M |
1 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
csrwin
|
88 |
38K |
12 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
88
|
38K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
csrwin
|
551 |
199K |
1 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
551
|
199K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
csrwin
|
5.1K |
2.5M |
7 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
csrwin
|
554 |
223K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
554
|
223K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
csrwin
|
551 |
199K |
5 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
199K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
csrwin
|
554 |
223K |
7 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
554
|
223K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
csrwin
|
590 |
221K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
590
|
221K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
csrwin
|
551 |
199K |
3 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
199K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
csrwin
|
551 |
199K |
11 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
199K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
csrwin
|
226 |
77K |
13 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
77K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
csrwin
|
17K |
6.6M |
1 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
17K
|
6.6M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
csrwin
|
17K |
6.6M |
31 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
17K
|
6.6M
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
csrwin
|
549 |
172K |
2 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
549
|
172K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
csrwin
|
549 |
172K |
1 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
549
|
172K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
csrwin
|
17K |
6.6M |
2 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
17K
|
6.6M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Charts
|
|
csrwin
|
83 |
38K |
2 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
83
|
38K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
csrwin
|
9.5K |
2.8M |
4 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
csrwin
|
549 |
172K |
9 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
549
|
172K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
csrwin
|
549 |
172K |
17 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
172K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Shareholder Class Action (VID268/2022) – Notice to Group Members
|
|
csrwin
|
168 |
97K |
4 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
168
|
97K
|
4
|
|